Di Renzo M, Zhou Z, George I, Becker K, Cunningham-Rundles C
Division of Clinical Immunology, The Mount Sinai Medical Center, New York City, NY, USA.
Clin Exp Immunol. 2000 Jun;120(3):503-11. doi: 10.1046/j.1365-2249.2000.01239.x.
CVID is a primary immune disorder in which hypogammaglobulinaemia may be associated with a number of T cell defects including lymphopenia, anergy, impaired lymphocyte proliferation and deficient cytokine secretion. In this study we show that T cells of CVID subjects, in comparison with control T cells, undergo spontaneous apoptosis in culture and markedly accelerated apoptosis after gamma-irradiation. Although costimulation of the CD28 receptor following engagement of the TCR/CD3 receptor normally provides a second signal necessary for IL-2 secretion, CD28 costimulation in CVID does not significantly increase IL-2 production, nor does this combination of activators enhance the survival of irradiated CVID T cells, as it does for cultured normal T cells. Addition of IL-2 enhances CVID T cell survival, suggesting that the IL-2 signalling pathways are normal. CVID T cells have similar expression of Bcl-2 to control T cells. CD3 stimulation up-regulates T cell expression of bcl-xL mRNA for normal T cells, but anti-CD28 does not augment bcl-xL expression for CVID subjects with accelerated apoptosis. Defects of the CD28 receptor pathway, leading to cytokine deprivation and dysregulation of bcl-xL, could lead to poor T cell viability and some of the cellular defects observed in CVID.
常见变异型免疫缺陷病(CVID)是一种原发性免疫疾病,其中低丙种球蛋白血症可能与多种T细胞缺陷相关,包括淋巴细胞减少、无反应性、淋巴细胞增殖受损和细胞因子分泌不足。在本研究中,我们发现与对照T细胞相比,CVID患者的T细胞在培养中会自发凋亡,且在γ射线照射后凋亡明显加速。虽然TCR/CD3受体结合后CD28受体的共刺激通常会提供IL-2分泌所需的第二个信号,但CVID中的CD28共刺激并不会显著增加IL-2的产生,而且这种激活剂组合也不会像对培养的正常T细胞那样增强受照射的CVID T细胞的存活。添加IL-2可提高CVID T细胞的存活率,这表明IL-2信号通路是正常的。CVID T细胞与对照T细胞的Bcl-2表达相似。CD3刺激可上调正常T细胞bcl-xL mRNA的T细胞表达,但抗CD28并不能增加凋亡加速的CVID患者的bcl-xL表达。CD28受体途径的缺陷导致细胞因子缺乏和bcl-xL失调,可能导致T细胞活力低下以及在CVID中观察到的一些细胞缺陷。